ART-020

N/A

Report date: 2025/08/14 15:01:08

Base Information

Drug NameART-020

Drug Alias NameART-020

ClassificationCell and gene therapy > Gene therapy > LNPCell and gene therapy > Gene therapy > mRNACell and gene therapy > Gene therapy > Gene editing

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsMuscular Dystrophy, Duchenne

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesArt BioScience

China Registration ClassN/A

Develop Information

Active CompaniesArt BioScience

Inactive CompaniesN/A

Active IndicationsMuscular Dystrophy, Duchenne

Inactive IndicationsN/A

Other Information

ATC CodeN/A